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INTRODUCTION:  Cholangiocarcinoma  is  a rare tumor  but recent  data  report  a worldwide  increase  in
incidence  and mortality.  There  are several  risk  factors  associated  with  cholangiocarcinoma,  and  chronic
inﬂammation  of billiary  tree seems  to be  implied  in  the  cholangiocarcinogenesis,  but  little  is  known  about
this  process.
PRESENTATION  OF CASE:  We  present  a 56-year-old  female  with  a bile  duct  adenoma  incidentally  discov-eywords:
holangiocarcinoma
holangiocarcinogenesis
denoma
reast carcinoma
ered  in the  follow  up  of breast  cancer  that  18  months  later  progress  to  intrahepatic  cholangiocarcinoma.
DISCUSSION:  This  is  a rare presentation  of  intrahepatic  cholangiocarcinoma  that  suggests  the  classic
adenoma-carcinoma  sequence  in  cholangiocarcinogenesis.  Furthermore  this  case  gives rise  to some
questions  about  the  possible  common  ground  on intrahepatic  cholangiocarcinoma  and  breast  cancer.
CONCLUSION: Cholangiocarcinogenesis  is  a  complex  multi-step  mechanism  and  further  investigations
are  needed  to fully  understand  this  process.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. . Introduction
Cholangiocarcinoma is a rare tumor, originated from epithelial
ells of biliary tree, which has become the second commonest pri-
ary hepatic tumor after hepatocellular carcinoma. Intrahepatic
holangiocarcinoma (ICC) accounts for 5–20% of cases1 and differ
n morphology, pathogenesis, risk factors, treatment and prognosis
o Extrahepatic Cholangiocarcinoma (ECC).2
Recent epidemiologic studies report a worldwide increase on
he incidence and mortality of ICC. In Portugal, from 1984 to 1996,
here was an increase in mortality of 10.4% on males and 10.3% on
emales.1 Clinical presentation is usually late with low (under 20%)
ates of surgical resectability.3 The 5-year survival rate is exceed-
ngly rare in unresectable lesions, and remains low in resected
umors even with clear margins.
Established predisposing factors for cholangiocarcinomas
ainly  concern ECCs and are related to chronic inﬂammation of the
iliary tract. Hepatitis C virus (HCV) infection represents a major
isk factor for ICC.2
The mechanisms involved in cholangiocarcinogenesis are
omplex and highly variable. Neoplastic transformation of the
holangiocytes appears to be driven by chronic inﬂammation and
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Open access under CC BYbile stasis following a multistep process initiated by the release of
growth promoting factors and cytokines.4
Malignant transformation of benign lesions such as Von Meyen-
burg Complexes (VMCs) and bile duct adenomas (BDAs) or
adenoﬁbromas have been described, leading to the hypothesis that
those might be premalignant lesions.
2. Presentation of case
We present a 56-year-old female submitted to a right mastec-
tomy. Pathology revealed a 10 mm ductal carcinoma in situ with
positivity for estrogen and progesterone receptors. Two years later,
a 31.8 mm nodule in liver segment V was observed in a scheduled
abdominal ultrasound (US) and in a Magnetic Resonance Imaging
(MRI) subsequently performed. The patient underwent a nodule
biopsy, the pathological exam revealing bile duct adenoma (Fig. 1).
The patient remained asymptomatic, with no evidence of nodule
growth or other changes in subsequent abdominal US  performed,
but 18 months later, MRI  revealed a growth of the nodule to
38.3 mm (Fig. 2
), with no evidence of extra-hepatic disease in several imagio-
logical studies. Tumor markers remained within the normal range.
A decision to resect was taken at our multidisciplinary Oncology
clinic based on tumoral growth.The patient underwent a right hepatectomy. The histologi-
cal exam revealed an intrahepatic cholangiocarcinoma with an
immuno-histochemical proﬁle matching that of the bile duct ade-
noma diagnosed on the previous biopsy (Fig. 3).
-NC-ND license. 
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Fig. 1. Bile duct adenoma.
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Fig. 2. MRI  reveals a 38.3 mm segment V nodule.Fig. 3. Cholangioc
. Discussion
Cholangiocarcinogenesis is a multi-step process. Chronic
nﬂammation of the biliary epithelium, associated to bile stasis, can
ead to cellular genetic damage, activating cholangiocyte turn-over.
urthermore, chronic inﬂammation creates a local environment
nriched in cytokines and growth factors (such as tumor growth
actor-beta and interleukin-6) that promote cellular proliferation
eading to hyperplasia and dysplasia.5 These genetic and epi-
enetic mutations eventually leads to cholangiocyte malignant
ransformation that results in dysregulation of apoptosis, enhanced
roliferation, stromal proliferation and neoangiogenesis.4
BDAs are almost always found incidentally as a solitary peri-
entimetric liver nodule. Pathologic diagnose may  represent a
hallenge especially if the lesion is large or shows extensive atypia.6
alignant transformation of benign lesions such as VMCs and BDAs
r adenoﬁbromas have been reported7,8 leading to the hypothesis
hat BDAs might be premalignant lesions.
In the case reported we present a rare presentation of ICC in a
atient with a BDA incidentally discovered in the follow up of breast
ancer, that 18 months later progress to ICC. This case suggests the
lassic adenoma–carcinoma sequence, well known in colo-rectal
ancer since Perry and Morson studies more than 30 years ago, but
eldom documented in biliary carcinogenesis, although BDAs are
isk factors for cholangiocarcinoma. We  cannot, however, exclude
he possibility of the cholangiocarcinoma diagnosis being missed
n the previous biopsy. That being the case, we must stress the
ndolent evolution of a usually aggressive carcinoma.ma (CK7+ CK19+).
Although never described, to our knowledge, the associa-
tion of breast carcinoma and intrahepatic cholangiocarcinoma,
we may  speculate that there might be a common biological
mechanism, namely hormonal. Several studies conﬁrm the exis-
tence of estrogen receptors in intrahepatic cholangiocarcinoma9
and that 17- estradiol promotes in vitro cellular proliferation
of cholangiocarcinoma, which is blocked by tamoxifen.10 The
lack of female preponderance in ICC and the much higher inci-
dence of breast cancer suggest that other mechanisms prevail in
cholangiocarcinogenesis.
4. Conclusion
Cholangiocarcinogenesis is a complex multi-step mechanism,
and chronic inﬂammation of the bile tract and bile stasis appears
to be the common pathological feature. Further investigations
are needed to fully understand this process in order to dis-
cover novel tools for an early diagnosis and an efﬁcacious speciﬁc
therapy.
The case reported describes a patient with an incidentally
discovered bile duct adenoma that months later progress to intra-
hepatic cholangiocarcinoma. This is a rare presentation of this
tumor and suggests the classic adenoma–carcinoma sequence
in cholangiocarcinogenesis. Furthermore this case gives rise to
some questions regarding hormonal inﬂuence in this complex
process.
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